[Metabolism and anti-convulsive action of 2-[beta-pyridyl-(2")-ethenyl]-3-(2'-methylphenyl)-quinazolinone-(4) (B169)].
D000818:Animals; D000927:Anticonvulsants / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology* / Q000652:urine; D001921:Brain / Q000378:metabolism; D002415:Cats; D002540:Cerebral Cortex / Q000187:drug effects; D004569:Electroencephalography; D005243:Feces / Q000032:analysis; D005260:Female; D006624:Hippocampus / Q000187:drug effects; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D011799:Quinazolines / Q000378:metabolism* / Q000494:pharmacology*; D011817:Rabbits; D012640:Seizures / Q000139:chemically induced; D013154:Spleen / Q000378:metabolism; D014316:Tritium
D000927:Anticonvulsants; D011799:Quinazolines; D014316:Tritium